Skip navigation

UCB SA

Pharmaceuticals
Belgium
Revenue (US$ Millions)$2,153
Revenue Growth (%)38.98%
Net Income (US$ Millions)$221
Earnings Per Share (US$)N/A
Total Equity (US$ Millions)$1,031
Profit Margin (%)10.28%
Debt To Equity Ratio (%)0.13%